Just released [1]. Very good summary of where things now stand, but also an informed view of where we might be headed.
Prof. Fizazi makes reference to the PEACE1 study that he is heading [2]. Arm B will receive "androgen deprivation therapy + docetaxel + abiraterone acetate + prednisone". If that turns out to me superior - & why not? - docetaxel & abiraterone acetate attack from two directions, men with newly diagnosed mets are going to suddenly be hit with a lot of stuff in the future.
Thanks Patrick. Do you know if there's been a follow up study on Latittude and Stampede? Just curious how the progression statistics is looking for those patients.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.